These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 27548322)
1. A Potential Nanofiber Membrane Device for Filling Surgical Residual Cavity to Prevent Glioma Recurrence and Improve Local Neural Tissue Reconstruction. Huang D; Lin C; Wen X; Gu S; Zhao P PLoS One; 2016; 11(8):e0161435. PubMed ID: 27548322 [TBL] [Abstract][Full Text] [Related]
2. A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide. Irani M; Mir Mohamad Sadeghi G; Haririan I Int J Biol Macromol; 2017 Apr; 97():744-751. PubMed ID: 28109815 [TBL] [Abstract][Full Text] [Related]
3. Gold coated poly (ε-caprolactonediol) based polyurethane nanofibers for controlled release of temozolomide. Irani M; Mir Mohamad Sadeghi G; Haririan I Biomed Pharmacother; 2017 Apr; 88():667-676. PubMed ID: 28152475 [TBL] [Abstract][Full Text] [Related]
4. Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide. Di Martino A; Pavelkova A; Maciulyte S; Budriene S; Sedlarik V Eur J Pharm Sci; 2016 Sep; 92():276-86. PubMed ID: 27154260 [TBL] [Abstract][Full Text] [Related]
5. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma. Ling Y; Wei K; Zou F; Zhong S Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964 [TBL] [Abstract][Full Text] [Related]
6. Establishment of nerve growth factor gradients on aligned chitosan-polylactide /alginate fibers for neural tissue engineering applications. Wu H; Liu J; Fang Q; Xiao B; Wan Y Colloids Surf B Biointerfaces; 2017 Dec; 160():598-609. PubMed ID: 29028608 [TBL] [Abstract][Full Text] [Related]
7. Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells. Chernov AN; Filatenkova TA; Glushakov RI; Buntovskaya AS; Alaverdian DA; Tsapieva AN; Kim AV; Fedorov EV; Skliar SS; Matsko MV; Galimova ES; Shamova OV Molecules; 2022 Aug; 27(15):. PubMed ID: 35956937 [TBL] [Abstract][Full Text] [Related]
9. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility. Dai X; Ma C; Lan Q; Xu T Biofabrication; 2016 Oct; 8(4):045005. PubMed ID: 27725343 [TBL] [Abstract][Full Text] [Related]
10. Temozolomide nano-in-nanofiber delivery system with sustained release and enhanced cellular uptake by U87MG cells. Shetty K; Yadav KS Drug Dev Ind Pharm; 2024 May; 50(5):420-431. PubMed ID: 38502031 [TBL] [Abstract][Full Text] [Related]
11. A naonoporous cell-therapy device with controllable biodegradation for long-term drug release. He H; Luedke E; Zhang X; Yu B; Schmitt A; McClarren B; Grignol V; Carson WE; Lee LJ J Control Release; 2013 Feb; 165(3):226-33. PubMed ID: 23228849 [TBL] [Abstract][Full Text] [Related]
12. Temozolomide Conjugated Carbon Quantum Dots Embedded in Core/Shell Nanofibers Prepared by Coaxial Electrospinning as an Implantable Delivery System for Cell Imaging and Sustained Drug Release. Shamsipour M; Mansouri AM; Moradipour P AAPS PharmSciTech; 2019 Jul; 20(7):259. PubMed ID: 31332574 [TBL] [Abstract][Full Text] [Related]
13. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment. Peng Y; Huang J; Xiao H; Wu T; Shuai X Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129 [TBL] [Abstract][Full Text] [Related]
14. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction. Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385 [TBL] [Abstract][Full Text] [Related]
15. The sustained delivery of temozolomide from electrospun PCL-Diol-b-PU/gold nanocompsite nanofibers to treat glioblastoma tumors. Irani M; Sadeghi GMM; Haririan I Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():165-174. PubMed ID: 28415451 [TBL] [Abstract][Full Text] [Related]
16. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells. Wang Y; Gao S; Wang W; Liang J Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252 [TBL] [Abstract][Full Text] [Related]
17. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth. Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126 [TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment. Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532 [TBL] [Abstract][Full Text] [Related]
19. Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation. Zhao Z; Shen J; Zhang L; Wang L; Xu H; Han Y; Jia J; Lu Y; Yu R; Liu H Biomater Sci; 2020 Sep; 8(19):5306-5316. PubMed ID: 32573615 [TBL] [Abstract][Full Text] [Related]
20. Development of a Spirulina Extract/Alginate-Imbedded PCL Nanofibrous Cosmetic Patch. Byeon SY; Cho MK; Shim KH; Kim HJ; Song HG; Shin HS J Microbiol Biotechnol; 2017 Sep; 27(9):1657-1663. PubMed ID: 28704904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]